ATH 33.3% 0.4¢ alterity therapeutics limited

Update, page-11

  1. 5,202 Posts.
    lightbulb Created with Sketch. 1139
    I knew this would happen...the EU following the FDA's lead. I said Prana would not approach the EU until cleared by the FDA. Well, the FDA hasn't released the PCH and now the EU has virtually said the same thing.
    How did I know this? Because I heard it from Kempler himself ages ago. In fact, shortly after the PCH was placed. So, in all that time since, the management has achieved absolutely nothing, zip, zilch. The PCH still stands. The EU has now blocked development as well (until dog studies are done and prove it is safe.)
    Meanwhile, Kempler continues to draw his (fat) salary.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.